Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients
Publication date
2002
Authors
Erkens, J.A.
Klungel, Olaf H.
Herings, R.M.C.
Stolk, R.P.
Spoelstra, J.A.
Grobbee, D.E.
Leufkens, H.G.
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health, SDG 3 - Good Health and Well-being
Citation
Erkens, J A, Klungel, O H, Herings, R M C, Stolk, R P, Spoelstra, J A, Grobbee, D E & Leufkens, H G M 2002, 'Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients', European Heart Journal, vol. 23, pp. 1575-1579.